Epithelial-to-mesenchymal transition and its role in EGFR-mutant lung adenocarcinoma and idiopathic pulmonary fibrosis.

about

The A2B Adenosine Receptor Modulates the Epithelial- Mesenchymal Transition through the Balance of cAMP/PKA and MAPK/ERK Pathway Activation in Human Epithelial Lung Cells.Survivin knockdown induces senescence in TTF‑1-expressing, KRAS-mutant lung adenocarcinomas.

P2860

Q50041957-4AB1FF79-9E76-46C9-B06E-14FC68832E58 Q52719185-D4D314AE-6EA3-471B-BB62-5198FAFC3291

P2860

Epithelial-to-mesenchymal transition and its role in EGFR-mutant lung adenocarcinoma and idiopathic pulmonary fibrosis.

Item

http://www.wikidata.org/entity/Q39415339

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Epithelial-to-mesenchymal tran ...... idiopathic pulmonary fibrosis.

@en

Epithelial-to-mesenchymal tran ...... idiopathic pulmonary fibrosis.

@nl

type

Item

label

Epithelial-to-mesenchymal tran ...... idiopathic pulmonary fibrosis.

@en

Epithelial-to-mesenchymal tran ...... idiopathic pulmonary fibrosis.

@nl

prefLabel

Epithelial-to-mesenchymal tran ...... idiopathic pulmonary fibrosis.

@en

Epithelial-to-mesenchymal tran ...... idiopathic pulmonary fibrosis.

@nl

P1476

Epithelial-to-mesenchymal tran ...... idiopathic pulmonary fibrosis.

@en

P2093

Yuji Sakuma

http://www.w3.org/2001/XMLSchema#string

P2860

Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin

Idiopathic pulmonary fibrosis: from epithelial injury to biomarkers--insights from the bench side

Novel mutant-selective EGFR kinase inhibitors against EGFR T790M

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.

Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC.

AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer

Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M.

Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations

Epidermal growth factor receptor mutations in lung cancer

P304

379-388

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PIN.12553

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28678431

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

adenocarcinoma

Epithelial-to-mesenchymal transition and its role in EGFR-mutant lung adenocarcinoma and idiopathic pulmonary fibrosis.

about

P2860

P2860

Epithelial-to-mesenchymal transition and its role in EGFR-mutant lung adenocarcinoma and idiopathic pulmonary fibrosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921